HLA-G and neoplasm: Specifically, compared with PD‐L1 Nb‐BiTE and HLA‐G Nb‐BiTE, the tumor growth inhibition was superior, and survival was prolonged significantly in mice after treatment with the dual‐targeting Nb‐TriTE in combination with PMBCs.